Blood tests during electroconvulsive therapy
Part of Mental health clinical trials.
This study looks at blood markers (substances in blood) measured during electroconvulsive therapy, to understand how the treatment is working in the body. If you’re already being considered for ECT, you may be asked for blood samples as part of this research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- You’ve been referred to the ECT clinic and have been accepted for ECT treatment
- You are able and willing to give informed consent (agree to join after learning the details)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This trial compares two anesthesia medicines—esketamine plus propofol versus methohexital—for people receiving ECT (electroconvulsive therapy) for severe depression. The goal is to see which anesthesia approach works better and is safer for patients during ECT.
This study tests a way of adjusting (titrating) ECT treatment to improve outcomes in people with major depression or bipolar II. It’s mainly for those who already need ECT with right-side electrode placement.
This study checks how well electroconvulsive therapy (ECT) works for people with major depression right after treatment and again 6 months later. You may be able to take part if you had ECT for major depression at the specified hospitals and agree to be included in a neurostimulation follow-up registry.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This study looks for ways to predict how well electroconvulsive therapy (ECT) will work for severe depression. It may help doctors choose the best treatment approach and timing for future patients.
Hear when a new Electroconvulsive Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.